Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta vs Abilify in Schizophrenia
NCT00299702Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of risperidone in schizophrenia, sponsored by Johnson & Johnson. Started Feb 2006; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00299702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299702.